Effects of ryanodine on skeletal muscle lactate and pyruvate in malignant hyperthermia-susceptible and normal swine as assessed by microdialysis
- PMID: 17686208
- DOI: 10.1017/S0265021507001238
Effects of ryanodine on skeletal muscle lactate and pyruvate in malignant hyperthermia-susceptible and normal swine as assessed by microdialysis
Abstract
Background: The caffeine/halothane contracture test in North America and the in vitro contracture test in Europe are currently the only validated bioassays for diagnosing malignant hyperthermia susceptibility and phenotyping families. Both tests are invasive requiring surgical muscle biopsy. Here, we report first use of the selective ryanodine receptor type I agonist ryanodine in a percutaneous microdialysis protocol designed to test whether microdialysis-induced local metabolic responses of skeletal muscle due to ryanodine receptor activation can differentiate between malignant hyperthermia-sensitive and normal pigs.
Methods: Six microdialysis catheters were implanted percutaneously into the adductor muscles of the right and left thighs of malignant hyperthermia-susceptible (n = 9) and normal (n = 8) anaesthetized (ketamine/propofol) and mechanically ventilated swine. Systemic blood gases, haemodynamic parameters and creatine kinase levels were measured before, during and after microdialysis perfusion of ryanodine. After a post-implantation equilibration period of 30 min, one catheter perfused (2 micro min-1) with 0.9% NaCl (control) and was compared with the remaining five catheters perfused with increasing concentrations of ryanodine (0.2-100 micromol). Lactate and pyruvate levels were measured enzymatically.
Results: Continuous perfusion with ryanodine revealed dose-dependent sigmoidal increases in the dialysate lactate and lactate-pyruvate ratio parameters; these effects were greatly augmented in malignant hyperthermia-susceptible pigs compared to normal pigs (two- to threefold): estimated EC50 greatly decreased (>19-fold) while the maximum effect increased (>twofold) in the malignant hyperthermia-susceptible group.
Conclusion: The in vivo percutaneous microdialysis protocol for skeletal muscle, using ryanodine as the ryanodine receptor type I agonist and dialysed lactate-pyruvate parameters as metabolic index, can reproducibly differentiate between malignant hyperthermia-susceptible and normal swine.
Similar articles
-
Effects of caffeine, halothane, and 4-chloro-m-cresol on skeletal muscle lactate and pyruvate in malignant hyperthermia-susceptible and normal swine as assessed by microdialysis.Anesthesiology. 2006 Jan;104(1):90-100. doi: 10.1097/00000542-200601000-00015. Anesthesiology. 2006. PMID: 16394695
-
The dose-response relationship and regional distribution of lactate after intramuscular injection of halothane and caffeine in malignant hyperthermia-susceptible pigs.Anesth Analg. 2006 Feb;102(2):468-72. doi: 10.1213/01.ane.0000189553.57833.11. Anesth Analg. 2006. PMID: 16428544
-
An in-vivo metabolic test for detecting malignant hyperthermia susceptibility in humans: a pilot study.Anesth Analg. 2008 Sep;107(3):909-14. doi: 10.1213/ane.0b013e31817e60b5. Anesth Analg. 2008. PMID: 18713904
-
Malignant hyperthermia.Science. 1992 May 8;256(5058):789-94. doi: 10.1126/science.1589759. Science. 1992. PMID: 1589759 Review.
-
The genetic basis of malignant hyperthermia.Trends Pharmacol Sci. 1992 Aug;13(8):330-4. doi: 10.1016/0165-6147(92)90101-b. Trends Pharmacol Sci. 1992. PMID: 1329295 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous